| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Andrology, Vol 14, Issue 2 79-86, Copyright © 1993 by The American Society of Andrology
JOURNAL ARTICLE |
T. C. Shao, A. Kong, P. Marafelia and G. R. Cunningham
Medical and Research Service, Department of Veterans Affairs Medical Center, Houston, Texas 77030.
The objectives of this study were to compare changes in the ventral prostate (VP) of young adult Sprague Dawley rats after 28 days of treatment with finasteride (F), a potent 5 alpha-reductase inhibitor, with those caused by castration (Cx). VP concentrations of DHT were reduced to 20.2% and 6.6% of controls (1,947 +/- 207 pg/VP, mean +/- SE) by F (5 or 20 mg/kg/day) and to 2.6% of controls by Cx. VP weights were reduced 49% and 54% by F and 88% by Cx. DNA/VP fell 25% and 15% with F treatment and 72% after Cx, whereas RNA and protein/VP were reduced 37-51% by F and 91-93% by Cx. The RNA/DNA and the protein/DNA ratios fell to 30-36% of controls after F treatment and to 70% of controls after Cx. The mRNA concentrations of the C3 subunit of prostatein 28S ribosomal RNA fell after treatment with F (5 mg/kg/day) and after Cx, whereas the mRNA for TRPM-2, an androgen-suppressed protein associated with apoptosis, was increased only after castration. To examine further the effects of F on the rate of DNA synthesis, 7-day regressed adult rats were treated for 3 days with testosterone propionate +/- F, and incorporation of 3H-thymidine in minced ventral prostates was determined. F inhibited 3H-thymidine incorporation. We conclude that Cx causes a greater reduction in cell number/VP and a greater reduction in RNA and protein cell than F and that the differences between F treatment and castration probably result from differences in prostatic concentrations of T.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
 |
|
 |
|
  S. E. Borst, C. F. Conover, C. S. Carter, C. M. Gregory, E. Marzetti, C. Leeuwenburgh, K. Vandenborne, and T. J. Wronski Anabolic effects of testosterone are preserved during inhibition of 5{alpha}-reductase Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E507 - E514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cayatte, C. Pons, J.-M. Guigonis, J. Pizzol, L. Elies, P. Kennel, D. Rouquie, R. Bars, B. Rossi, and M. Samson Protein Profiling of Rat Ventral Prostate following Chronic Finasteride Administration: Identification and Localization of a Novel Putative Androgen-regulated Protein Mol. Cell. Proteomics, November 1, 2006; 5(11): 2031 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Borst, J. H. Lee, and C. F. Conover Inhibition of 5{alpha}-reductase blocks prostate effects of testosterone without blocking anabolic effects Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E222 - E227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Gao, J. D. Kearbey, V. A. Nair, K. Chung, A. F. Parlow, D. D. Miller, and J. T. Dalton Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5{alpha}-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia Endocrinology, December 1, 2004; 145(12): 5420 - 5428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Wright, R. C. Douglas, L. N. Thomas, C. B. Lazier, and R. S. Rittmaster Androgen-Induced Regrowth in the Castrated Rat Ventral Prostate: Role of 5{alpha}-Reductase Endocrinology, October 1, 1999; 140(10): 4509 - 4515. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
